Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
SLAM BioTherapeutics Logo
SLAM BioTherapeutics Growth Score
54
CB Rank
510285
Heat Score
35
SLAM BioTherapeutics is a Biotechnology Research centre.
Private11-50 slambio.com
Biotechnology
Overview

SLAM BioTherapeutics
Growth Score
54
Heat Score
35

Growth Score54
-5 pts
in past quarter
Heat Score 35
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About SLAM BioTherapeutics

CB Rank
510285
SLAM BioTherapeutics is a Biotechnology Research centre.
Private11-50 slambio.com
Biotechnology

Key People

  • Photo of Chan Whiting
    Chan Whiting: Chief Scientific Officer
    Past Role: Aduro BioTech, Director and Head of Immune Monitoring and Biomarker Development
  • Photo of Steve Potts
    Steve Potts: Chief Executive Officer
    Past Role: OncoMyx Therapeutics, Chief Executive Officer & Founder

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3

Employee Profiles

News

News and Press

News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 5, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

519

IT Spend

$34KThis year, SLAM BioTherapeutics is projected to spend $34K on IT, according to Aberdeen.

Active Website Tech Count

11SLAM BioTherapeutics is actively using 11 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Apple Mobile Web Clips Icon.
Sub-Organizations
Frequently Asked Questions

Who are SLAM BioTherapeutics's competitors? Alternatives and possible competitors to SLAM BioTherapeutics may include Agenus, AbCellera, and  A2 Biotherapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(c936496 1)
|